# Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients

> **NCT02933736** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Nader Sanai** · enrollment: 48 (estimated)

## Conditions studied

- Glioblastoma Multiforme
- Meningioma

## Interventions

- **DRUG:** Ribociclib

## Key facts

- **NCT ID:** NCT02933736
- **Lead sponsor:** Nader Sanai
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-10-17
- **Primary completion:** 2023-03-01
- **Final completion:** 2027-03
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933736, "Ribociclib (LEE011) in Preoperative Glioma and Meningioma Patients". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02933736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*